MASTEK Mastek Q1 FY27 results (Apr–Jun 2026) and concall
Mastek Limited reported a mixed Q1 FY27, with revenue growing 1.2% sequentially in USD ($104.8 million) and 5% in INR (₹985 crore). The company demonstrated strong order book growth, with the 12-month backlog increasing 25% YoY to $310 million, driven by a significant $25 million AI transformation deal in North America. However, operating EBITDA was impacted, standing at 15.4%, primarily due to geopolitical headwinds in the Middle East, increased bench costs, and delayed collections. The UK Healthcare sector also saw a temporary decline in top client revenue due to project transitions, while t
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 7.7%, net profit up 15.2% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 870 | 905 | 915 | 940 | 906 +4% | 938 +4% | 985 +8% |
| EBITDA | 141 | 139 | 137 | 146 | 152 +8% | 151 +9% | 152 +11% |
| Net profit | 95 | 81 | 92 | 97 | 108 +14% | 106 +31% | 106 +15% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
